Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIα

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 71-81

  Syrovets, Tatiana ^a   Büchele, Berthold ^a   Gedig, Erk ^b   Slupsky, Joseph R ^a   Simmet, Thomas ^a  

^a UNIVERSITY OF ULM   (Germany)

^b XanTec Analysensysteme   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOSWELLIC ACID; DNA TOPOISOMERASE INHIBITOR; GYRASE INHIBITOR;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME BINDING; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL;

EID: 0342646956     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.71     Document Type: Article

References (40)

1. Andoh T and Ishida R (1998) Catalytic inhibitors of DNA topoisomerase II. Biochim Biophys Acta 1400:155-171.
2. Baguley BC and Ferguson LR (1998) Mutagenic properties of topoisomerase-targeted drugs. Biochim Biophys Acta 1400:213-222.
3. Benchokroun Y, Couprie J and Larsen AK (1995) Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells. Biochem Pharmacol 49:305-313.
4. Berger JM, Fass D, Wang JC and Harrison SC (1998) Structural similarities between topoisomerases that cleave one or both strands. Proc Natl Acad Sci USA 95:7876-7881.
5. Boege F, Biersack H and Meyer P (1994) Drug-sensitivity and DNA-binding of a subform of topoisomerase II alpha in resistant human HL-60 cells. Acta Oncol 33:799-806.
6. Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, Andersen A, Jacob F and Köhrle J (1996) Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 271:2262-2270.
7. Burden DA and Osheroff N (1998) Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1400:139-154.
8. Capranico G, Binaschi M, Borgnetto ME, Zunino F and Palumbo M (1997) A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol Sci 18:323-329.
9. Fortune JM and Osheroff N (1998) Merbarone inhibits the catalytic activity of human topoisomerase IIα by blocking DNA cleavage. J Biol Chem 273:17643-17650.
10. Frydman B, Marton LJ, Sun JS, Neder K, Witiak DT, Liu AA, Wang HM, Mao Y, Wu HY, Sanders MM and Liu LF (1997) Induction of DNA topoisomerase II-mediated DNA cleavage by beta-lapachone and related naphthoquinones. Cancer Res 57: 620-627.
11. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nuñez G, Krammer PH, Peter ME and Debatin KM (1997) Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res 57:4956-4964.
12. Gatto B, Sanders MM, Yu C, Wu H-Y, Mahkey D, LaVoie EJ and Liu LF (1996) Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne. Cancer Res 56:2795-2800.
13. Gupta I, Gupta V, Parihar A, Gupta S, Lüdtke R, Safayhi H and Ammon HPT (1998) Effects of Boswellia Serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 3:511-514.
14. Hande KR (1998) Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim Biophys Acta 1400:173-184.
15. Heldt MR, Syrovets T, Winking M, Sailer ER, Safayhi H, Ammon HPT and Simmet T (1997) Boswellic acids exhibit cytotoxic effects on brain tumor cells independent from 5-lipoxygenase inhibition. Naunyn-Schmiedeberg's Arch Pharmacol 355 (Suppl):30.
16. Hoernlein RF, Orlikowsky Th, Zehrer C, Niethammer D, Sailer ER, Simmet T, Dannecker GE and Ammon HPT (1999) Acetyl-11-keto-β-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I. J Pharmacol Exp Ther 288:613-619
17. Hsu HY, Yang JJ and Lin CC (1997) Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 111:7-13.
18. Jensen LH, Nitiss KC, Rose A, Dong J, Zhou J, Hu T, Osheroff N, Jensen PB, Sehested M and Nitiss JL (2000) A novel mechanism of cell killing by antitopoisomerase II bisdioxopiperazines. J Biol Chem 275: 2137-2146.
19. Mannherz HG, Peitsch MC, Zanotti S, Paddenberg R and Polzar B (1995) A new function for an old enzyme: The role of DNase I in apoptosis. Curr Topics Microbiol Immunol 198:161-174
20. Muller MT, Pfund WP, Mehta VB and Trask DK (1985) Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. EMBO (Eur Mol Biol Organ) J 4:1237-1243.
21. Noda Y, Kaiya T, Kohda K and Kawazoe Y (1997) Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: Possibility of a new mode of cell killing. Chem Pharm Bull 45:1665-1670.
22. O'Shannessy DJ, Brigham-Burke M, Soneson KK, Hensley P and Brooks I (1993) Determination of rate and equilibrium binding constants for macromolecular interactions by surface plasmon resonance. Anal Biochem 212:457-468.
23. Osheroff N (1986) Eukaryotic topoisomerase II. Characterization of enzyme turnover. J Biol Chem 261:9944-9950.
24. Pilch DS, Yu C, Makhey D, LaVoie EJ, Srinivasan AR, Olson WK, Sauers RS, Breslauer KJ, Geacintov NE and Liu LF (1997) Minor groove-directed and intercalative ligand-DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs. Biochemistry 36:12542-12553.
25. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, Das Gupta TKW and Pezutto JM (1995) Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1:1046-1051.
26. Pommier Y, Minford JK, Schwartz RE, Zwelling LA and Kohn K (1985) Effects of the DNA intercalators 4′-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. Biochemistry 24:6410-6416.
27. Pommier Y, Pourquier P, Fan Y and Strumberg D (1998) Mechanism of action of eukaryotic topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1400:83-106.
28. Redinbo MR, Champoux JJ and Hol WG (1999) Structural insights into the function of type IB topoisomerases. Curr Opin Struct Biol 9:29-36.
29. Roca J, Ishida R, Berger JM, Andoh T and Wang JC (1994) Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci USA 91:1781-1785.
30. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR and Ammon HPT (1992) Boswellic acids: Novel specific nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261:1143-1146.
31. Shao Y, Ho C-T, Chin C-K, Badmaev V, Ma W and Huang MT (1998) Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med 64:328-331.
32. Sim S-P, Gatto B, Yu C, Liu AA, Li T-K, Pilch DS, La Voie EJ and Liu LF (1997) Differential poisoning of topoisomerases by menogaril and nogalamycin dictated by the minor groove-binding nogalose sugar. Biochemistry 36:13285-13291.
33. Sorensen M, Sehested M and Jensen PB (1997) pH-dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine. Biochem Pharmacol 54:373-380.
34. Spitzner JR, Chung IK and Muller MT (1990) Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucleic Acids Res 88:1-11.
35. Tanabe K, Ikegami Y, Ishida R and Andoh T (1991) Inhibition of topoisomerase II by antitumor agents bis(26-dioxopiperazine) derivatives. Cancer Res 51:4903-4908.
36. Trask DK, DiDonato JA and Muller MT (1984) Rapid detection and isolation of covalent DNA/protein complexes: Application to topoisomerase I and II. EMBO (Eur Mol Biol Organ) J 3:671-676.
37. Waring MJ (1981) DNA modification and cancer. Annu Rev Biochem 50:159-192.
38. Winterstein A and Stein G (1932) Untersuchungen in der Saponinreihe. Zur Kenntnis der Mono-oxy-triterpensäuren. Hoppe-Seylers Z Physiol Chem 20:9-25.
39. Withoff S, De Jong S, De Vries EGE and Mulder NH (1996) Human DNA topoisomerase II: Biochemistry and role in chemotherapy resistance. Anticancer Res 16: 1867-1880.
40. Xu Z, Li TK, Kim JS, LaVoie EJ, Breslauer KJ, Liu LF and Pilch DS (1998) DNA minor groove binding-directed poisoning of human DNA topoisomerase I by terbenzimidazoles. Biochemistry 37:3558-3566.